Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.655
-0.155 (-3.22%)
At close: Jun 30, 2026, 4:00 PM EDT
4.630
-0.025 (-0.54%)
After-hours: Jun 30, 2026, 7:36 PM EDT
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $365.52 million as of June 30, 2026. Its market cap has increased by 69.13% in one year.
Market Cap
365.52M
Enterprise Value
179.84M
1-Year Change
69.13%
Ranking
Category
Stock Price
$4.66
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $365.52M, an increase of 34.70%. That is a compound annual growth rate of 11.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 365.52M | -49.57% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 398.97M |
| DiaMedica Therapeutics | 389.04M |
| Compass Therapeutics | 388.99M |
| Palisade Bio | 387.08M |
| Fennec Pharmaceuticals | 383.15M |
| Upstream Bio | 377.13M |
| OmniAb | 372.58M |
| Vanda Pharmaceuticals | 369.23M |